Acadia Pharmaceuticals
ACAD
ACAD
245 hedge funds and large institutions have $2.12B invested in Acadia Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 69 increasing their positions, 88 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
23% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 47
40% less capital invested
Capital invested by funds: $3.56B → $2.12B (-$1.44B)
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Holders
245
Holding in Top 10
2
Calls
$25.3M
Puts
$17.4M
Top Buyers
| 1 | +$59.5M | |
| 2 | +$30.7M | |
| 3 | +$24.4M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$21.7M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$10.8M |
Top Sellers
| 1 | -$55.1M | |
| 2 | -$32M | |
| 3 | -$16.8M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.3M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$14.3M |